Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor

BACKGROUND: Opioid analgesics are the most effective drugs for the treatment of moderate to severe pain. However, they also produce several adverse effects that can complicate pain management. The μ opioid (MOP) receptor, a G protein-coupled receptor, is recognized as the opioid receptor type which...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben Haddou, Tanila, Malfacini, Davide, Calo, Girolamo, Aceto, Mario D, Harris, Louis S, Traynor, John R, Coop, Andrew, Schmidhammer, Helmut, Spetea, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121618/
https://www.ncbi.nlm.nih.gov/pubmed/25059282
http://dx.doi.org/10.1186/1744-8069-10-48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121618/
https://www.ncbi.nlm.nih.gov/pubmed/25059282
http://dx.doi.org/10.1186/1744-8069-10-48

Ejemplares similares